Blood test, glucose (blood sugar)
Facility: Kansas Spine & Specialty Hospital, Llc
Billing Code: 82947 (CPT)
- CPT Billing Code: 82947
- Insurance Median: $4
- Cash Discount Price: $29
- vs. Medicare Baseline: 1.02x Medicare
Average discount available for prompt cash payment at this facility.
Median negotiated contract rate across all mapped commercial carriers.
Standard federal government reimbursement rate for this code.
Visual Cost Comparison vs. Medicare
Understanding this gauge: We use the federal Medicare rate of $3.93 as the cost baseline. Rates below the baseline represent excellent value. In-network commercial rates commonly hover around 150% - 250% of Medicare, while rates exceeding 300% are elevated. Hover over the green and blue markers to view detailed calculations.
Out-of-Pocket Cost Estimator
Estimate whether it is more economical to use your insurance or pay the upfront self-pay cash rate.
Commercial Insurance Negotiated Rates
Negotiated contract ranges established by major commercial carriers at this facility.
| Carrier / Plan Group | Contract Rate Range | vs. Medicare Reference |
|---|---|---|
| Providrs Care Network | $4 | 102% |
| UnitedHealthcare | $4 - $5 | 102% |
| Blue Cross Blue Shield | $4 | 102% |
| United Mine Workers Of America | $4 | 102% |
| Humana | $4 | 102% |
| Aetna | $4 - $5 | 102% |
| Lantern Specialty Care | $6 | 153% |
Consumer Guidance & Cost Commentary
For the CPT code 82947, representing a blood test for glucose, Kansas Spine & Specialty Hospital, Llc in Wichita, KS, lists a cash median price of $29.00. This cash rate is significantly lower than the facility's gross charge of $44.00 and aligns closely with the state average, which is often used as a benchmark for fair market value. While the facility is a Physician-owned Acute Care Hospital with seven different payers, including UnitedHealthcare and Blue Cross Blue Shield, the negotiated rates vary widely, ranging from $4.00 to $5.00 depending on the specific insurance plan. Because commercial negotiated rates can sometimes exceed the cash price due to administrative overhead and contract dynamics, patients with high-deductible plans may find paying the $29.00 cash median more cost-effective than relying on insurance, provided they qualify for the facility's self-pay or prompt-pay discounts.
It is important to note that while the No Surprises Act protects patients from balance billing for out-of-network services at in-network facilities, unexpected charges can still occur if ancillary services like specific lab components are billed separately. Consumers should request a full itemized bill before paying to ensure no unbundled codes or services not rendered are included, as summary bills often obscure these details. Additionally, since the facility's Medicare amount is $3.93, any commercial rate should be evaluated against this federal baseline rather than the inflated gross charge to determine true value. Patients are encouraged to contact the billing department directly to confirm their specific plan's allowed amount and to ask about prompt-pay incentives that could further reduce the final cost before scheduling the test.